Results 71 to 80 of about 2,106 (155)

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO₂TECT Randomized Clinical Trial of ESA-Naïve Patients. [PDF]

Kidney Med, 2023
Winkelmayer WC, Arnold S, Burke SK, Chertow GM, Eckardt KU, Jardine AG, Lewis EF, Luo W, Matsushita K, McCullough PA, Minga T, Parfrey PS.   +11 more
europepmc   +1 more source

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO₂TECT Randomized Clinical Trial of ESA-Treated Patients. [PDF]

Kidney Med, 2023
Parfrey PS, Burke SK, Chertow GM, Eckardt KU, Jardine AG, Lewis EF, Luo W, Matsushita K, McCullough PA, Minga T, Winkelmayer WC.   +10 more
europepmc   +1 more source

Iron status and erythropoiesis response to darbepoetin alfa in dogs with chronic kidney disease. [PDF]

J Vet Med Sci, 2021
Bhamarasuta C, Premratanachai K, Mongkolpinyopat N, Yothapand P, Vejpattarasiri T, Dissayabutra T, Trisiriroj M, Sutayatram S, Buranakarl C.   +8 more
europepmc   +1 more source

Darbepoetin-alfa [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. [PDF]

Int J Hematol, 2022
Morita Y, Nannya Y, Ichikawa M, Hanamoto H, Shibayama H, Maeda Y, Hata T, Miyamoto T, Kawabata H, Takeuchi K, Tanaka H, Kishimoto J, Miyano S, Matsumura I, Ogawa S, Akashi K, Kanakura Y, Mitani K.   +17 more
europepmc   +1 more source

A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD. [PDF]

J Am Soc Nephrol, 2021
Toto R, Petersen J, Berns JS, Lewis EF, Tran Q, Tran Q, Weir MR.   +6 more
europepmc   +1 more source

Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients. [PDF]

Ther Apher Dial, 2021
Akizawa T, Yamaguchi Y, Majikawa Y, Reusch M.   +3 more
europepmc   +1 more source

Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD. [PDF]

J Am Soc Nephrol, 2021
Nangaku M, Kondo K, Kokado Y, Ueta K, Kaneko G, Tandai T, Kawaguchi Y, Komatsu Y.   +7 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study. [PDF]

Nephrol Dial Transplant, 2021
Nangaku M, Kondo K, Ueta K, Kokado Y, Kaneko G, Matsuda H, Kawaguchi Y, Komatsu Y.   +7 more
europepmc   +1 more source